Experimental: Cohort A and Cohort B

Cohort A: Participants with Juvenile-Onset RRP (J-O RRP; age at first diagnosis <12 years) will be administered one injection of INO-3107 intramuscular (IM) injection followed by electroporation (EP) using CELLECTRA™ 2000 at Day 0, Week 3, Week 6, and Week 9. Cohort B: Participants with Adult-Onset RRP (A-O RRP; age at first diagnosis ≥ 12 years) will be administered one injection of INO-3107 intramuscular (IM) injection followed by EP using CELLECTRA™ 2000 at Day 0, Week 3, Week 6, and Week 9.


Drug: INO-3107

INO-3107 administered by IM injection followed by EP using CELLECTRA™ 2000 device at Day 0, Week 3, 6, and 9.


Device: CELLECTRA™ 2000

CELLECTRA™ 2000 device used for EP following IM delivery of INO-3107.



Source link